Technology Appraisal Committee Meeting (Committee D): Tuesday 28 September 2010
The closing date to register for The Technology Appraisal meeting (Committee D) being held on 28 September 2010 has now passed.
The meeting will start promptly at 10:00 and is expected to finish at approximately 17:00
Refreshments will be served from 09:30
Venue: At NICE, Level 1, City Tower, Piccadilly Plaza, Manchester, M1 4BD
Please note that this agenda is subject to change prior to the meeting.
Final Agenda
1. Welcome and introduction to format of meeting
2. Apologies
3. Any other business
4. Minutes from the last Committee meeting held on 25 August 2010
5. Appraisal of Golimumab for the treatment of rheumatoid arthritis after failure of previous disease-modifying antirheumatic drugs
5.1 Evidence Review Group attendance - School of Health and Related Research (ScHARR):
- Sarah Davis, Senior Lecturer in Health Economics
- Dr Rachel Jackson, Research Associate
- Jon Tosh, Research Associate in Cost-Effectiveness Modelling
5.2. Clinical specialist attendance:
- Clinical specialist, nominated by British Society for Rheumatology
- Clinical specialist, nominated by National Clinical Guideline Centre
5.3. Patient expert attendance:
- Patient expert, nominated by National Rheumatoid Arthritis Society
- Patient expert, nominated by National Rheumatoid Arthritis Society
5.4. Manufacturer representatives from:
- Merck Sharp & Dohme Limited (MSD)
5.5. Declarations of interest - Part 1 only (open session)
5.6. Introduction by the Chair, Professor Peter Clark - Part 1 only (open session)
5.7. Presentation by the Lead team, Dr Matthew Bradley, Dr Philip Rutledge - Part 1 AND Part 2 (open and closed session)
5.8. Agreement on the content of the Appraisal Consultation Document (ACD) or Final Appraisal Determination (FAD) - Part 2 only (closed session)
6. Appraisal of Bevacizumab in combination with oxaliplatin and either 5FU or capecitabine for the treatment of metastatic colorectal cancer
6.1. Evidence Review Group attendance - School of Health and Related Research (ScHARR):
- Dr Matt Stevenson, Technical Director
- Dr Sophie Whyte, Research Associate in Cost-Effectiveness Modelling
6.2. Manufacturer representatives from:
- Roche Ltd
6.3. Declarations of interest - Part 1 only (open session)
6.4. Introduction by the Chair, Professor Peter Clark - Part 1 only (open session)
6.5. Presentation by the Chair, Professor Peter Clark - Part 1 AND Part 2 (open and closed session)
6.6. Agreement on the content of the Final Appraisal Determination (FAD) - Part 2 only (closed session)
Date, time and venue of next meeting
Next Technology Appraisal Committee Meeting (Committee D) - Wednesday 27 October 2010, 10:00am, Level 1, City Tower, Piccadilly Plaza, Manchester, M1 4BD.
Please note all timings are approximate.
To register
To allow wider public access, NICE may allow up to two representatives per organisation, however, where a meeting is oversubscribed, NICE reserves the right to limit representatives to one per organisation.
Should you have queries regarding attending this meeting, please contact the Meetings in Public Coordinator Sarah Gage.
The closing date for registration is Tuesday 14 September 2010 at 5pm
The closing date to register for The Technology Appraisal meeting (Committee D) being held on 28 September 2010 has now passed.
This page was last updated: 23 September 2010
